(Press-News.org) Women who have a tubal ligation – the surgical tying or severing of fallopian tubes to prohibit pregnancy – have less frequent Pap smears, which puts them at an increased risk for cervical cancer, according to research recently released by a team that included Cara A. Mathews, MD, a gynecologic oncologist at the Program in Women's Oncology at Women & Infants Hospital of Rhode Island.
The findings were part of the National Cancer Institute-funded study "Study to Understand Cervical Cancer Endpoints and Determinants" being conducted when Dr. Mathews was a fellow at the University of Oklahoma. The results were published in late 2012 in the professional journal Gynecologic Oncology.
The objective, according to Dr. Mathews, was to investigate any connection between different types of contraception, screening frequency and cancer rates. Study participants were women who underwent a colposcopy after having an abnormal Pap test. The researchers used a questionnaire to identify factors associated with the cancer, including the frequency that the women went for Pap tests.
A Pap test checks for changes in the cells of a woman's cervix. The test can tell if the woman has an infection, abnormal cervical cells or cervical cancer, and has led to a major decline in the number of cervical cancer cases and deaths.
"Previously, we have advised women to have a Pap test every two years starting at age 21," Dr. Mathews explains. "Women over the age of 30 with three or more normal Pap tests were able to space screening intervals to every three years. And women over 65 without risk factors do not need to keep screening."
She and her colleagues, however, discovered that women who have had a tubal ligation were not as likely to have regular Pap tests.
"In all age groups, women with tubal ligation were more likely to have had no Pap screening in the previous five years compared to women using other forms of contraception," Dr. Mathews reveals.
The research publication came on the tail of new recommended Pap guidelines from the American College of Gynecology (ACOG), which state that women between 21 and 65 without risk factors should be screened every three years. Women ages 30 to 65 who want to extend the screening interval can go every five years.
"In issuing the new guidelines, ACOG stressed the importance of emphasizing well visits and screenings in women, including the Pap test, to promote health and prevent cancer," Dr. Mathews concludes.
###
For more information about personal testing, women can call their gynecologist or family care practitioner. For a list of physicians accepting new patients, they can call Women & Infants' Physician Referral Line at 1-800-921-9299. Women diagnosed with cervical cancer or who have had an abnormal Pap test can be referred to the Program in Women's Oncology at 401-453-7520.
About Women & Infants Hospital
Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation's leading specialty hospitals for women and newborns. The primary teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women's medicine, Women & Infants is the eighth largest stand-alone obstetrical service in the country with nearly 8,400 deliveries per year. In 2009, Women & Infants opened the country's largest, single-family room neonatal intensive care unit.
New England's premier hospital for women and newborns, Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation's only mother-baby perinatal psychiatric partial hospital, as well as the nation's only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Center of Excellence from the American College of Radiography; a Center for In Vitro Maturation Excellence by SAGE In Vitro Fertilization; a Center of Biomedical Research Excellence by the National Institutes of Health; and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute's Gynecologic Oncology Group and the National Institutes of Health's Pelvic Floor Disorders Network. END
Research makes connetion between tubal ligation and increase in cervical cancer rates
2013-01-14
ELSE PRESS RELEASES FROM THIS DATE:
Liver controls wasting in cancer
2013-01-14
Cachexia or wasting is a condition affecting up to 70 percent of cancer patients, depending on the type of cancer. It is characterized by a dramatic loss of body weight that is independent of food intake. Cachexia is seen particularly often and most pronounced in patients suffering from cancers of the digestive tract and the lungs. They may lose up to 80 percent of body fat and skeletal muscle. Muscle loss leads to weakness and immobility of patients and poorer response to treatment. An estimated 20 percent of cancer deaths are considered to be a direct consequence of cachexia, ...
Dynamic, dark energy in an accelerating universe
2013-01-14
This press release is available in Spanish.
It was cosmology that drew Irene Sendra from Valencia to the Basque Country. Cosmology alsogave her the chance to collaborate with one of the winners of the 2011 Nobel Prize for Physics on one of the darkest areas of the universe. And dark matter and dark energy, well-known precisely because so little is known about them, are in fact the object of the study bySendra, a researcher in the Department of Theoretical Physics and History of Science of the UPV/EHU's Faculty of Science and Technology.
"Observations tell us that ...
NRL designs multi-junction solar cell to break efficiency barrier
2013-01-14
WASHINGTON -- U.S. Naval Research Laboratory scientists in the Electronics Technology and Science Division, in collaboration with the Imperial College London and MicroLink Devices, Inc., Niles, Ill., have proposed a novel triple-junction solar cell with the potential to break the 50 percent conversion efficiency barrier, which is the current goal in multi-junction photovoltaic development.
"This research has produced a novel, realistically achievable, lattice-matched, multi-junction solar cell design with the potential to break the 50 percent power conversion efficiency ...
Using lysine estimates to detect heat damage in DDGS
2013-01-14
URBANA – Distillers dried grains with solubles (DDGS) are a good source of energy and protein in swine diets. However, they can be damaged by excessive heat during processing, compromising their nutritional value. University of Illinois researchers have found that it is possible to assess heat damage by predicting the digestibility of lysine in DDGS.
Excessive heat causes some of the lysine in DDGS to bond with sugars and form Amadori compounds. The lysine bound in these compounds is called unreactive lysine; pigs cannot digest it. Lysine that is not bound is referred ...
Amino acid studies may aid battle against citrus greening disease
2013-01-14
This press release is available in Spanish.Amino acids in orange juice might reveal secrets to the successful attack strategy of the plant pathogen that causes citrus greening disease, also known as Huanglongbing or HLB. Studies of these amino acids by U.S. Department of Agriculture (USDA) chemist Andrew P. Breksa III and University of California-Davis professor Carolyn M. Slupsky may pave the way to a safe, effective, environmentally friendly approach to undermine Candidatus Liberibacter asiaticus, the microbial culprit behind HLB.
The scientists used nuclear magnetic ...
ASH international clinical collaboration replicates high cure rate of APL in developing countries
2013-01-14
(WASHINGTON) – Data published online today in Blood, the Journal of the American Society of Hematology (ASH) describe the work of an ASH international clinical network collaborative focused on modernizing treatment protocols for patients in the developing world with acute promyeloctyic leukemia (APL) that has drastically improved cure rates in patients in Central and South America, achieving comparable outcomes to those observed in patients in the United States and in Europe.
APL is a rare, aggressive cancer of the blood and bone marrow that can be fatal in a matter ...
Better care from doctors who are culturally aware
2013-01-14
HIV patients from ethnic minorities receive better quality of care from doctors and other primary healthcare professionals who are the most competent at caring for patients from diverse backgrounds – those who are "culturally competent." These patients also tend to manage both their treatment and condition better, according to a new study¹ by Somnath Saha from Portland VA Medical Center, and the Oregon Health & Science University in the US, and colleagues. Their findings appear in the Journal of General Internal Medicine², published by Springer.
The authors explored whether ...
The secret sex life of the penicillin-producing fungus could make it more productive
2013-01-14
New and more effective strains of the fungus used to produce penicillin could be developed after a team of international scientists unearthed the secret sex life of Sir Alexander Fleming's fungus Penicillium chrysogenum (P. chrysogenum).
The scientists from The University of Nottingham, Ruhr-University Bochum, The University of Göttingen, and Sandoz GmbH have announced a major breakthrough in our understanding of the sex life of the fungus P. chrysogenum. Their research looks sets to lead to the introduction of new and more effective strains of the world's first antibiotic ...
Parkinson's treatment can trigger creativity
2013-01-14
Parkinson's experts across the world have been reporting a remarkable phenomenon — many patients treated with drugs to increase the activity of dopamine in the brain as a therapy for motor symptoms such as tremors and muscle rigidity are developing new creative talents, including painting, sculpting, writing, and more.
Prof. Rivka Inzelberg of Tel Aviv University's Sackler Faculty of Medicine first noticed the trend in her own Sheba Medical Center clinic when the usual holiday presents from patients — typically chocolates or similar gifts — took a surprising turn. "Instead, ...
Team finds gene that promotes drug resistance in cancer
2013-01-14
Scientists from the University of Iowa and Brigham Young University (BYU) have identified a gene that may be a target for overcoming drug resistance in cancer. The finding could not only improve prognostic and diagnostic tools for evaluating cancer and monitoring patients' response to treatment but also could lead to new therapies directed at eradicating drug-resistant cancer cells.
Drug resistance is a common problem in many metastatic cancers. It leads to failure of chemotherapy treatments and is associated with poor patient outcomes, including rapid relapse and death.
The ...